Global Viral Conjunctivitis Drugs Market 2016-2020 - Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Viral Conjunctivitis Drugs Market in subject line and your contact details. Read 53 Pages Report at http://www.reportsnreports.com/reports/509025-global-viralconjunctivitis-drugs-market-2016-2020.html . Viral conjunctivitis, or pink eye, is a type of infectious conjunctivitis that is commonly caused by an adenovirus. Herpes simplex virus (HSV), picornavirus (enterovirus 70, Coxsackie A24), varicella-zoster virus, poxvirus (molluscum contagiosum and vaccinia), and human immunodeficiency virus (HIV) are some of the other viruses that are responsible for the infection. Discomfort through watery discharge is the main symptom of this highly contagious condition. It is often associated with keratoconjunctivitis, which results in slightly blurred vision. No specific treatment option is available for the infection, which heals by itself in 2-3 weeks. Antibiotics and anti-inflammatory drugs are used only if the condition persists. In certain instances, when the infection is serious or persists for weeks, topical antiviral drugs are used. Corneal lesions persist for months even after the condition heals. The analysts forecast global viral conjunctivitis drugs market to grow at a CAGR of 2.41% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global viral conjunctivitis drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used for the treatment and prevention of viral conjunctivitis. The market is divided into the following segments based on geography:   
Americas APAC EMEA
The report, Global Viral Conjunctivitis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=509025 for US $2500.
Global Viral Conjunctivitis Drugs Market 2016-2020
Key vendors
Akorn Alcon Allergan Bausch & Lomb
Other prominent vendors
Adenovir Pharma Marinomed Biotechnologie Mediolanum Laboratoires NanoViricides Nicox Novartis Panoptes Pharma Rapid Pathogen Screening Shire Starpharma Valeant Pharmaceuticals
Inquire before Buying at http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=509025 . Market driver
Rising awareness
Market challenge
Low diagnosis rate
Market trend
Use of off-label drugs
Key questions answered in this report 1. 2. 3. 4. 5.
What will the market size be in 2020 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space?
Global Viral Conjunctivitis Drugs Market 2016-2020
6. What are the market opportunities and threats faced by the key vendors? 7. What are the strengths and weaknesses of the key vendors? Inquire for Discount at http://www.reportsnreports.com/contacts/Discount.aspx?name=509025 . List of Exhibits Exhibit 01: Product offerings Exhibit 02: Types of conjunctivitis Exhibit 03: Major types of viral conjunctivitis Exhibit 04: Signs and symptoms of types of viral conjunctivitis Exhibit 05: Diagnostic algorithm for viral conjunctivitis Exhibit 06: Drugs used to treat conjunctivitis Exhibit 07: Comparison of prevalent rates in different types of conjunctivitis among adults and pediatric population (%) Exhibit 08: Global viral conjunctivitis drugs market: Pipeline portfolio Exhibit 09: Global viral conjunctivitis drugs market 2015-2020 ($ millions) Exhibit 10: Snapshot of global viral conjunctivitis drugs market Exhibit 11: Percentage share of US in the global viral conjunctivitis drugs market 2015 Exhibit 12: Viral conjunctivitis drugs market in US 2015-2020 ($ millions) Exhibit 13: Five forces analysis Exhibit 14: Global viral conjunctivitis drugs market segment by route of administration Exhibit 15: Global viral conjunctivitis drugs market by geography 2015 Exhibit 16: Viral conjunctivitis drugs market by geography 2015-2020 ($ millions) Exhibit 17: Viral conjunctivitis drugs market in Americas 2015-2020 ($ millions) Exhibit 18: Viral conjunctivitis drugs market in EMEA 2015-2020 ($ millions) Global Viral Conjunctivitis Drugs Market 2016-2020
Exhibit 19: Viral conjunctivitis drugs market in APAC 2015-2020 ($ millions) Exhibit 20: Global viral conjunctivitis drugs market: YoY growth and revenue based on geography 2015-2020 Exhibit 21: Impact of drivers Exhibit 22: Impact of drivers and challenges Exhibit 23: Akorn: YOY growth and revenue generated from ophthalmic segment 2011-2013 ($ millions) Exhibit 24: Akorn: Key takeaways Exhibit 25: Alcon: Business segmentation by revenue 2014 Exhibit 26: Alcon: YoY growth and revenue generated from sales of ophthalmic products 20112014 ($ billions) Exhibit 27: Alcon: Key takeaways Exhibit 28: Allergan: Key takeaways Exhibit 29: Bausch & Lomb: Key takeaways Browse All Reports on Pharmaceuticals About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
Global Viral Conjunctivitis Drugs Market 2016-2020